pDONR223_Luciferase Citations (4)

Originally described in: A public genome-scale lentiviral expression library of human ORFs.
Yang X, Boehm JS, Yang X, Salehi-Ashtiani K, Hao T, Shen Y, Lubonja R, Thomas SR, Alkan O, Bhimdi T, Green TM, Johannessen CM, Silver SJ, Nguyen C, Murray RR, Hieronymus H, Balcha D, Fan C, Lin C, Ghamsari L, Vidal M, Hahn WC, Hill DE, Root DE Nat Methods. 2011 Jun 26. ():. PubMed Journal

---

Articles Citing pDONR223_Luciferase

Articles
Simultaneous targeting of PI3Kdelta and a PI3Kdelta-dependent MEK1/2-Erk1/2 pathway for therapy in pediatric B-cell acute lymphoblastic leukemia. Wang X, Zhang X, Li BS, Zhai X, Yang Z, Ding LX, Wang H, Liang C, Zhu W, Ding J, Meng LH. Oncotarget. 2014 Nov 15;5(21):10732-44. PubMed
Expression of transgenes enriched in rare codons is enhanced by the MAPK pathway. Peterson J, Li S, Kaltenbrun E, Erdogan O, Counter CM. Sci Rep. 2020 Dec 17;10(1):22166. doi: 10.1038/s41598-020-78453-5. PubMed
TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment. Maddalena M, Mallel G, Nataraj NB, Shreberk-Shaked M, Hassin O, Mukherjee S, Arandkar S, Rotkopf R, Kapsack A, Lambiase G, Pellegrino B, Ben-Isaac E, Golani O, Addadi Y, Hajaj E, Eilam R, Straussman R, Yarden Y, Lotem M, Oren M. Proc Natl Acad Sci U S A. 2021 Jun 8;118(23). pii: 2025631118. doi: 10.1073/pnas.2025631118. PubMed
Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer. Vichas A, Riley AK, Nkinsi NT, Kamlapurkar S, Parrish PCR, Lo A, Duke F, Chen J, Fung I, Watson J, Rees M, Gabel AM, Thomas JD, Bradley RK, Lee JK, Hatch EM, Baine MK, Rekhtman N, Ladanyi M, Piccioni F, Berger AH. Nat Commun. 2021 Aug 9;12(1):4789. doi: 10.1038/s41467-021-24841-y. PubMed

If you have published an article using this material, please email us at to have your article added to this page.